Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans.12/15/2022 - 11/30/2025 (Multi-PI)
PI:
Andrew Emili, PhDNIH/National Institute on Aging1RF1AG075832-01A1
Multiscale analysis of metabolic inflammation as a driver of breast cancer09/09/2020 - 08/31/2025 (Multi-PI)
PI:
Andrew Emili, PhDNIH/National Cancer Institute5U01CA243004-04
Genetic Modifiers of Protein Interaction Networks in Tauopathy08/01/2019 - 03/31/2025 (Multi-PI)
PI:
Andrew Emili, PhDNIH/National Institute on Aging5R01AG064932-05
Systems-level functional proteomics analysis assemblies in Alzheimer's disease and mouse models of tauopathy02/15/2019 - 06/30/2024 (Multi-PI)
PI:
Andrew Emili, PhDNIH/National Institute on Aging1RF1AG061706-01
RAPID: Transcription Factor Profiling for SARS-CoV2 Tolerance/Symbiosis Regulation06/01/2020 - 05/31/2023 (Multi-PI)
PI:
Andrew Emili, PhDNational Science FoundationIOS-2031624
Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis05/06/2021 - 08/31/2022 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI146941-02
Mapping Pathogenic Coronavirus Viral-Host Protein Interaction Environments for Target Discovery08/03/2020 - 01/02/2022 (Multi-PI)
PI:
Andrew Emili, PhDMerck, Sharp & Dohme LLC
A new human iPSC in vitro system to model the inception of lung adenocarcinoma (2nd Year Renewal - WWDA)12/01/2020 - 12/31/2021 (Multi-PI)
PI:
Andrew Emili, PhDJanssen Research & Development, LLC
Engineering a smart CAR platform for human regulatory T cells09/30/2019 - 09/29/2021 (Co-Investigator)
PI:
Wilson Wong, PhDNIH/National Institute of Biomedical Imaging & Bioengineering1R56EB027729-01A1
A new human iPSC in vitro system to model the inception of
lung adenocarcinoma06/01/2020 - 11/30/2020 (Multi-PI)
PI:
Andrew Emili, PhDJohnson & Johnson Enterprise Innovation, Inc.
Showing 10 of 13 results.
Show All Results
Mapping the blood cell protein complexosome07/01/2017 - 05/31/2020 (Subcontract PI)
University of Texas at Austin NIH NIDDK5R01DK110520-03
Understanding the etiology of airway carcinomas via global proteomic, phospho-proteomic and metabolomic analyses01/01/2019 - 12/31/2019 (Co-Investigator)
PI:
Xaralabos Varelas, PhDJohnson & Johnson
A new human iPSC in vitro system to model the inception of lung adenocarcinoma01/01/2019 - 12/31/2019 (Co-Investigator)
PI:
Darrell Nelson Kotton, MDJohnson & Johnson